Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 11 | 2020 | 53 | 1.740 |
Why?
|
| Polysomnography | 10 | 2020 | 94 | 0.880 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2017 | 58 | 0.790 |
Why?
|
| Continuous Positive Airway Pressure | 5 | 2009 | 18 | 0.780 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 43 | 0.780 |
Why?
|
| Sleep | 3 | 2017 | 318 | 0.700 |
Why?
|
| Actigraphy | 2 | 2017 | 98 | 0.610 |
Why?
|
| Monitoring, Ambulatory | 1 | 2009 | 20 | 0.350 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 40 | 0.350 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 20 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2009 | 201 | 0.330 |
Why?
|
| Patient Compliance | 2 | 2007 | 165 | 0.330 |
Why?
|
| Hospitals, Public | 1 | 2007 | 31 | 0.290 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 35 | 0.290 |
Why?
|
| Middle Aged | 15 | 2018 | 9963 | 0.270 |
Why?
|
| Rhinitis | 2 | 2018 | 165 | 0.250 |
Why?
|
| Body Mass Index | 7 | 2020 | 425 | 0.250 |
Why?
|
| Sinusitis | 2 | 2018 | 187 | 0.240 |
Why?
|
| Female | 17 | 2020 | 16430 | 0.230 |
Why?
|
| Male | 15 | 2018 | 15871 | 0.220 |
Why?
|
| Microvascular Angina | 1 | 2002 | 1 | 0.200 |
Why?
|
| Chronobiology Disorders | 1 | 2002 | 14 | 0.200 |
Why?
|
| Minority Groups | 1 | 2002 | 67 | 0.190 |
Why?
|
| Melatonin | 1 | 2002 | 96 | 0.190 |
Why?
|
| Hypertension | 2 | 2007 | 272 | 0.190 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 7 | 0.180 |
Why?
|
| Sepsis | 1 | 2002 | 147 | 0.180 |
Why?
|
| Humans | 18 | 2020 | 29852 | 0.180 |
Why?
|
| Obesity | 2 | 2005 | 290 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 52 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2020 | 112 | 0.160 |
Why?
|
| Severity of Illness Index | 5 | 2011 | 1126 | 0.160 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 7 | 0.160 |
Why?
|
| Habits | 1 | 2017 | 2 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 59 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2017 | 1824 | 0.140 |
Why?
|
| Obesity, Morbid | 2 | 2007 | 74 | 0.140 |
Why?
|
| Kidney | 1 | 2017 | 176 | 0.130 |
Why?
|
| Sleep, REM | 2 | 2020 | 18 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 97 | 0.130 |
Why?
|
| Comorbidity | 3 | 2018 | 504 | 0.130 |
Why?
|
| Adult | 8 | 2020 | 8748 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 161 | 0.120 |
Why?
|
| Prevalence | 2 | 2009 | 494 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2018 | 286 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2018 | 1953 | 0.110 |
Why?
|
| Illinois | 2 | 2017 | 241 | 0.100 |
Why?
|
| Chicago | 2 | 2016 | 867 | 0.100 |
Why?
|
| Behavior Therapy | 1 | 2011 | 77 | 0.090 |
Why?
|
| Ondansetron | 1 | 2010 | 1 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 19 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 532 | 0.090 |
Why?
|
| Fluoxetine | 1 | 2010 | 33 | 0.090 |
Why?
|
| Aged | 5 | 2018 | 9621 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 80 | 0.090 |
Why?
|
| Age Distribution | 1 | 2009 | 95 | 0.080 |
Why?
|
| Risk Factors | 3 | 2020 | 2467 | 0.080 |
Why?
|
| Equipment Design | 1 | 2009 | 186 | 0.080 |
Why?
|
| Recurrence | 1 | 2009 | 355 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2009 | 403 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2018 | 3325 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 23 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2007 | 31 | 0.080 |
Why?
|
| Gastroplasty | 1 | 2007 | 21 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 71 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2007 | 22 | 0.070 |
Why?
|
| Algorithms | 1 | 2009 | 401 | 0.070 |
Why?
|
| Demography | 1 | 2007 | 78 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2007 | 143 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 103 | 0.070 |
Why?
|
| Liver | 1 | 2007 | 175 | 0.070 |
Why?
|
| Hypercapnia | 1 | 2006 | 1 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 508 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2016 | 3561 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 140 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 1969 | 0.050 |
Why?
|
| Adolescent | 3 | 2020 | 2334 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2020 | 39 | 0.040 |
Why?
|
| United States | 2 | 2007 | 2346 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2002 | 312 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 410 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 388 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 643 | 0.040 |
Why?
|
| Snoring | 1 | 2017 | 5 | 0.040 |
Why?
|
| Quality of Life | 2 | 2016 | 677 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 64 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 64 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2007 | 61 | 0.030 |
Why?
|
| Health Behavior | 1 | 2016 | 159 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 214 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 193 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 970 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2011 | 31 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1641 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 33 | 0.020 |
Why?
|
| Fatigue | 1 | 2011 | 63 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 327 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 230 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 245 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 456 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 522 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 507 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 4 | 0.020 |
Why?
|
| Hepatitis | 1 | 2007 | 9 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2007 | 32 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2007 | 23 | 0.020 |
Why?
|
| Weight Loss | 1 | 2007 | 101 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 68 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2007 | 192 | 0.020 |
Why?
|
| Length of Stay | 1 | 2007 | 320 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2005 | 3 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1462 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 1859 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 283 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 957 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 1187 | 0.010 |
Why?
|